Itron (NASDAQ:ITRI) SVP Donald Reeves III Sells 255 Shares

Key Points

  • Itron SVP Donald Reeves III sold 255 shares on May 21 at an average price of $80.88, totaling about $20,624. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
  • Itron’s latest earnings beat expectations, with quarterly EPS of $1.49 versus the $1.26 consensus and revenue of $586.98 million above estimates. However, revenue still declined 3.3% year over year.
  • Analysts remain broadly positive on the stock: Stephens kept an Overweight rating with a $130 target, and the overall consensus is a Moderate Buy with a $131.22 average price target. Some firms, however, have trimmed future earnings estimates.

Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Donald Reeves III sold 255 shares of the company's stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $80.88, for a total value of $20,624.40. Following the completion of the transaction, the senior vice president directly owned 29,419 shares of the company's stock, valued at $2,379,408.72. The trade was a 0.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Itron Stock Performance

NASDAQ ITRI opened at $83.02 on Friday. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 13.24, a PEG ratio of 0.72 and a beta of 1.35. Itron, Inc. has a twelve month low of $77.77 and a twelve month high of $142.00. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. The stock has a 50-day moving average of $88.45 and a 200 day moving average of $94.52.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to analysts' expectations of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.Itron's quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Sell-side analysts anticipate that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Key Itron News




Here are the key news stories impacting Itron this week:

  • Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
  • Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
  • Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Oppenheimer upped their price target on Itron from $133.00 to $135.00 and gave the stock an "outperform" rating in a report on Thursday, April 16th. Guggenheim set a $155.00 price target on Itron in a report on Friday, February 13th. Raymond James Financial assumed coverage on Itron in a report on Tuesday, April 21st. They issued an "underperform" rating for the company. Robert W. Baird set a $128.00 price target on Itron and gave the stock an "outperform" rating in a report on Wednesday, February 18th. Finally, Roth Mkm reiterated a "buy" rating and set a $136.00 price objective on shares of Itron in a research note on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $131.22.

View Our Latest Analysis on Itron

Institutional Investors Weigh In On Itron

Several large investors have recently bought and sold shares of ITRI. Vanguard Group Inc. grew its position in shares of Itron by 2.3% in the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company's stock valued at $731,809,000 after purchasing an additional 132,329 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company's stock valued at $197,153,000 after purchasing an additional 890,040 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Itron by 20.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company's stock valued at $137,659,000 after purchasing an additional 265,039 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Itron by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company's stock valued at $106,340,000 after purchasing an additional 6,598 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its position in shares of Itron by 6.0% in the third quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company's stock valued at $124,545,000 after purchasing an additional 56,318 shares in the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Recommended Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Itron?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Itron and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles